Sign Up to like & get
recommendations!
1
Published in 2021 at "Experimental cell research"
DOI: 10.1016/j.yexcr.2021.112929
Abstract: Cervical cancer (CC) is among the most prevalent gynecological malignancies. Participation of long non-coding RNA (lncRNA) in modulating biological behaviors of CC cells has been confirmed. However, the function of lncRNA ABHD11 antisense RNA 1…
read more here.
Keywords:
abhd11;
rna;
abhd11 as1;
mark2 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Nature Chemical Biology"
DOI: 10.1038/s41589-025-01965-6
Abstract: Glutarate is an intermediate of amino acid catabolism and an important metabolite for reprogramming T cell immunity. Glutarate exerts its effects either by directly inhibiting metabolite-dependent enzymes or through conjugation to substrates. Intriguingly, glutarylation can…
read more here.
Keywords:
cell metabolism;
metabolism;
tca cycle;
abhd11 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_201812_16627
Abstract: OBJECTIVE Accumulating evidence showed aberrant expressions of long non-coding RNAs (lncRNAs) strongly correlated to the development of cancers, including pancreatic cancer (PC). Whether lncRNA ABHD11-AS1 (ABHD11-AS1) is involved in PC remains to be elucidated. Thus,…
read more here.
Keywords:
pi3k;
abhd11;
pancreatic cancer;
abhd11 as1 ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Non-Coding RNA"
DOI: 10.3390/ncrna8020021
Abstract: The aberrant expression of lncRNAs has been linked to the development and progression of different cancers. One such lncRNA is ABHD11 antisense RNA 1 (ABHD11-AS1), which has recently gained attention for its significant role in…
read more here.
Keywords:
human malignancies;
clinical significance;
rna;
abhd11 as1 ... See more keywords